PAVmed Inc. (NASDAQ: PAVM) reported Q2 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $525 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.